With studies showing that sustained intraocular VEGF neutralisation results in neurodegeneration (Hombrebueno et al., 2015) but not vascular damage (Lechner et al., 2019) in the retina during diabetes, there is an unmet need to target pathways to prevent disease progression in the early stages of DR. Here, VEGFA is linked to diabetes mellitus.